Beijing BGI-GBI Biotech Co., Ltd.
北京华大吉比爱生物技术有限公司
Complete regulatory portfolio for Beijing BGI-GBI Biotech Co., Ltd. in China's medical device market. This registrant has 146 medical devices registered with China NMPA, with registrations dating from Apr 10, 2017 to Nov 21, 2024.
Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.
Free Database
Powered by Pure Global AI
NMPA Official Data
146 Devices
Company Overview
Total Devices
146
Province/Region
Beijing
北京
Address
Room 236, Room 237, Building 1, No. 538, Yongfeng Tun, Haidian District, Beijing
北京市海淀区永丰屯538号1号楼236、237室
Registration Timeline
Earliest Approval
Apr 10, 2017
Latest Approval
Nov 21, 2024
Device Class Distribution
Breakdown of 146 devices by regulatory classification
Class II
81
55.5% of total
Class III
65
44.5% of total
Registered Devices (10 most recent shown)
Click on any device for detailed registration information